BioCentury
ARTICLE | Clinical News

Eniluracil: Phase I suspended enrollment

November 24, 2008 8:00 AM UTC

Adherex said it has temporarily suspended enrollment in a U.S. Phase I trial after a reprioritization of its development programs. The trial, which has enrolled 41 patients, is evaluating oral enilura...